Fangfang Jing
PLA Medical School No 28 Fuxing Road
Haidian, 100853, China
Haidian, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Immune Checkpoint Inhibitor Without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A Real-World Retrospective Study.
Journal: Clinical lung cancer
Published: May 08, 2025
Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma.
Journal: Frontiers in pharmacology
Published: February 28, 2025
The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report.
Journal: Clinical lung cancer
Published: July 18, 2023
Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China.
Journal: Frontiers in oncology
Published: January 19, 2023
XRCC2 Polymorphisms and Environmental Factors Predict High Risk of Colorectal Cancer.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 12, 2018
Association between interleukin-8 -251A/T polymorphism and risk of lung cancer: a meta-analysis.
Journal: Cancer investigation
Published: October 15, 2014
Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.
Journal: International journal of clinical and experimental medicine
Published: October 07, 2014
Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.
Journal: World journal of surgical oncology
Published: October 23, 2013
Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy.
Journal: World journal of surgical oncology
Published: May 10, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026